“The Balancing Act between Equity and Sustainability”. This year’s conference recognizes the need to promote and protect the human rights of all persons, including the estimated 300 million persons living with a rare disease worldwide, many of whom are children, by ensuring equal opportunities to achieve their optimal potential development and to participate in society [...]
The official presentation of the 25 Factories passed the selection within “Estrazione dei Talenti” (Talents mining) action will be held on January 29th, 2020 in Bari, Italy, at the pavilion of the Apulia Region, Fiera del Levante. The event, organised by the Regional Agency for Technology and Innovation – ARTI, is opened to the audience [...]
Patients involvement in the development of paediatric clinical trials is recognized as an important added value at European and international level and an essential contribution to paediatric clinical research. […]
PARIS (31 January 2017) – The European Clinical Research Infrastructure Network (ECRIN) has announced the launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN). The three-year project brings together ECRIN and the founding partners of the European Paediatric Clinical Trial Research Infrastructure (EPCT-RI) to develop capacity for the management of multinational paediatric clinical trials. Children [...]
The Italian contribution and the new INCiPiT research network coordinated by the University Paediatric Hospital Bambino Gesù. 2016 is the first year in which a significant increase of new drugs approved by the EMA (European Medicines Agency) for the paediatric population has been observed. There are 36 new molecules now in distribution: drugs for the [...]
The last day of the SMART project’s Summer School, organized by Consorzio Valutazioni Biologiche e Farmacologiche moved to Canosa di Puglia, at the headquarters of Farmalabor, an Apulian company founded in 2001 with the aim of enhancing and spreading the culture of galenic formulations. To do so, it manufactures and markets raw materials (active ingredients [...]
The paediatric research asserts itself in Europe as a sector of great interest. It was estimated that for the Paediatric Regulation’s effect, the EMA (the European Medicines Agency), has launched about 800 new pediatric clinical trials that will require the involvement of 210,000 pediatric patients in the forthcoming years. […]
On 5th April, 2015, “Corriere del Mezzogiorno”, the special insert of the national newspaper Corriere della Sera, have published an article focused on the launch of the first edition of International Master in Regulatory Sciences (IMRS) facing the Mediterranean countries, sponsored by Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus. The Master, organized in collaboration [...]
On March 1st, 2015 the national newspaper Corriere della Sera published, on its special issue Sezione Salute, an article entirely dedicated to CVBF and its contributions and goals in the fields of rare diseases and paediatrics. The article, entitled “Rare diseases and Paediatrics: the goals of the Consorzio per Valutazioni Biologiche e Farmacologiche – Clinical [...]
On February 27th, 2015, the national newspaper Corriere della Sera has published on its section “Corriere Sociale,” dedicated to volunteering and Third Sector, an article on CVBF and its activities in the field of rare diseases and paediatrics. The page describes the four main focus areas of the Consortium: Clinical Trials (promotion of an ethical [...]
